New therapies for severe meningococcal disease.
Giroir
B P
BP
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D023181:Antimicrobial Cationic Peptides; D001770:Blood Bactericidal Activity; D001798:Blood Proteins / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008565:Membrane Proteins; D008589:Meningococcal Infections / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000911:Antibodies, Monoclonal; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D008565:Membrane Proteins; D011994:Recombinant Proteins; C021623:bactericidal permeability increasing protein